SCHEMBL17295415

SCHEMBL17295415

O=C1C(=Cc2ccc3[nH]ccc3c2)SC(=NCc2ccccc2)N1CCCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.51
▸ MAPT P10636 3/20 0.51
▸ HPGD P15428 1/20 0.51
▸ NPSR1 Q6W5P4 2/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ GAA P10253 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ S1PR1 P21453 4/20 0.48
▸ S1PR3 Q99500 4/20 0.48
▸ LMNA P02545 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ PTPN1 P18031 3/20 0.39
▸ ACP1 P24666 1/20 0.39
▸ AKR1B1 P15121 6/20 0.38
▸ PTPN2 P17706 2/20 0.38
▸ ENPP2 Q13822 1/20 0.38
▸ NLRP3 Q96P20 1/20 0.38
▸ FAAH O00519 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17295414 1.00 ALDH1A1 (0.51) ALDH1A1MAPTHPGDNPSR1MEN1
SCHEMBL17295268 0.94 MAPT (0.52) ALDH1A1MAPTHPGDNPSR1MEN1
SCHEMBL17295269 0.94 MAPT (0.52) ALDH1A1MAPTHPGDNPSR1MEN1
SCHEMBL29726504 0.94 MAPT (0.52) ALDH1A1MAPTHPGDNPSR1MEN1
SCHEMBL17295630 0.92 ALDH1A1 (0.52) ALDH1A1MAPTHPGDNPSR1MEN1
SCHEMBL17295628 0.92 ALDH1A1 (0.52) ALDH1A1MAPTHPGDNPSR1MEN1
SCHEMBL17295392 0.89 PTPN1 (0.51) HPGDS1PR1S1PR3LMNAPTPN1
SCHEMBL17295389 0.89 PTPN1 (0.51) HPGDS1PR1S1PR3LMNAPTPN1
SCHEMBL17295287 0.84 ALDH1A1 (0.49) ALDH1A1MAPTHPGDNPSR1MEN1
SCHEMBL17295285 0.84 ALDH1A1 (0.49) ALDH1A1MAPTHPGDNPSR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148990-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2017-04-05 — — EP disclosed
WO-2015181337-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2015-12-03 — — WO disclosed
Send feedback